Skip to main content
. 2020 Feb 3;11(8):2060–2067. doi: 10.7150/jca.37991

Figure 2.

Figure 2

Kaplan-Meier plot of PFS (A) and TTST (B) in EGFR-mutated advanced NSCLC patients with or without acquired T790M mutation. PFS, progression-free survival from the EGFR-TKI treatment to PD or death; TTST, time to subsequent treatment from the EGFR-TKI treatment to subsequent treatment or death; CI, confidence interval.